Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk mapk rasgap ras p21'

Search results for: 'research area mapk mapk rasgap ras p21'

Items 1-10 of 39

Page
per page
  1. K-Ras(G12C) inhibitor 6
    B3694 K-Ras(G12C) inhibitor 6
    Target: KRAS G12C
    Summary: K-Ras (G12C) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.25 mg/mL
  2. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  3. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  4. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  5. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  6. CC-930
    A3288 CC-930
    Target: JNK
    Summary: JNK inhibitor,potent and selective
      Soluble in DMSO
  7. JNK-IN-7
    A3519 JNK-IN-7
    Target: JNK
    Summary: Selective JNK inhibitor
      ≥24.7 mg/mL
  8. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  9. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  10. PD184352 (CI-1040)
    A1792 PD184352 (CI-1040)
    Target: MEK
    Summary: Selective MEK inhibitor
      ≥47.9 mg/mL

Items 1-10 of 39

Page
per page